Skip to main content
OpenTrials

Clinical trial condition

Adenoma

Explore clinical trials studying Adenoma. Study availability and eligibility vary by location and protocol.

597 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Adenoma trial results

Completed

A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

NCT02875548

Conditions
Adenoma, Advanced Solid Tumors, Diffuse Large B-Cell Lymphoma (DLBCL), +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • California Cancer Associates For Research And Excellence, cCARE Santa Fe, California, United States
  • Hematology Oncology Associates of the Treasure Coast - Port St. Lucie Port Saint Lucie, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 34 locations
View Trial Details
Completed

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

NCT02214134

Conditions
Adenoma, Any Stage of Any Thymic Malignancy, Any Stage of Lung Cancer (Any Histotype), +14 more
Locations
  • Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
  • U.Z. Leuven - Campus Gasthuisberg Leuven, Belgium
  • CHU de Lyon - Hopital Louis Pradel Lyon, France
View all 18 locations
View Trial Details
Completed

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

NCT03126110

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +82 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University - Siteman Cancer Center St Louis, Missouri, United States
View all 38 locations
View Trial Details
Completed

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

NCT02903914

Conditions
Adenocarcinoma, Adenoma, Bladder Cancer, +49 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Honor Health/Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Georgetown Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)

NCT04153565

Conditions
Adenoma, Mesothelioma, Neoplasms, +4 more
Locations
  • Hyogo College of Medicine Hospital ( Site 0003) Nishinomiya, Hyōgo, Japan
  • Kanagawa Cancer Center ( Site 0004) Yokohama, Kanagawa, Japan
  • JOHAS Okayama Rosai Hospital ( Site 0002) Okayama, Japan
  • National Cancer Center Hospital ( Site 0001) Tokyo, Japan
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details

Related conditions